Edesa Biotech, Inc. (EDSA)
2.74
-0.08
(-2.84%)
USD |
NASDAQ |
Oct 21, 16:00
2.74
0.00 (0.00%)
After-Hours: 18:25
Edesa Biotech Price : 2.74 for Oct. 21, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 2.81 | 3.025 | 2.81 | 2.82 | 35515.00 |
| Oct 19, 2026 | 2.57 | 2.918 | 2.57 | 2.78 | 25040.00 |
| Oct 16, 2026 | 2.68 | 2.766 | 2.52 | 2.57 | 64032.00 |
| Oct 15, 2026 | 2.62 | 2.79 | 2.541 | 2.67 | 75822.00 |
| Oct 14, 2026 | 2.84 | 2.84 | 2.62 | 2.65 | 72593.00 |
| Oct 13, 2026 | 2.89 | 3.09 | 2.815 | 2.845 | 61373.00 |
| Oct 12, 2026 | 3.56 | 3.56 | 2.87 | 2.94 | 81659.00 |
| Oct 09, 2026 | 3.61 | 3.76 | 3.49 | 3.51 | 36472.00 |
| Oct 08, 2026 | 3.96 | 3.96 | 3.66 | 3.66 | 51919.00 |
| Oct 07, 2026 | 3.77 | 4.01 | 3.77 | 3.895 | 20192.00 |
| Oct 06, 2026 | 3.91 | 4.00 | 3.72 | 3.72 | 12830.00 |
| Oct 05, 2026 | 3.80 | 4.22 | 3.80 | 3.91 | 69953.00 |
| Oct 02, 2026 | 4.01 | 4.01 | 3.81 | 3.86 | 18454.00 |
| Oct 01, 2026 | 4.15 | 4.16 | 3.910 | 4.01 | 15489.00 |
| Sep 30, 2026 | 3.57 | 4.27 | 3.51 | 4.21 | 84916.00 |
| Sep 29, 2026 | 3.59 | 3.73 | 3.47 | 3.56 | 41249.00 |
| Sep 28, 2026 | 4.040 | 4.040 | 3.638 | 3.65 | 48340.00 |
| Sep 25, 2026 | 4.04 | 4.095 | 3.97 | 4.01 | 16765.00 |
| Sep 24, 2026 | 3.90 | 4.150 | 3.90 | 4.03 | 29568.00 |
| Sep 23, 2026 | 4.02 | 4.09 | 3.97 | 3.97 | 25466.00 |
| Sep 22, 2026 | 4.02 | 4.20 | 4.02 | 4.07 | 26115.00 |
| Sep 21, 2026 | 4.17 | 4.235 | 3.99 | 4.11 | 42034.00 |
| Sep 18, 2026 | 4.03 | 4.14 | 4.01 | 4.14 | 41397.00 |
| Sep 17, 2026 | 3.93 | 4.20 | 3.91 | 4.14 | 24799.00 |
| Sep 16, 2026 | 4.08 | 4.12 | 3.840 | 3.87 | 94424.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ProMIS Neurosciences, Inc. | 9.035 |
| Arrowhead Pharmaceuticals, Inc. | 58.83 |
| Oncolytics Biotech, Inc. | 0.5142 |
| Sangamo Therapeutics, Inc. | 0.11 |
| Sarepta Therapeutics, Inc. | 18.57 |
Price Related Metrics
| PEG Ratio | -0.0593 |
| Price to Book Value | 66.15 |
| Earnings Yield | -61.74% |
| Market Cap | 26.39M |
| PEGY Ratio | -0.0593 |